1-4 of 4
David Cunningham
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors

Franck Morschhauser, Jean-Pascal Machiels, Gilles Salles, Sylvie Rottey, Simon A.J. Rule, David Cunningham, Frederic Peyrade, Christophe Fruchart, Hendrik-Tobias Arkenau, Isabelle Genvresse, Li Liu, Karl Köchert, Kui Shen, Christoph Kneip, Carol E. Peña, Joachim Grevel, Jun Zhang, Galia Cisternas, Susanne Reschke, Camille Granvil, Ahmad Awada
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2020) 19 (2): 468–478.
https://doi.org/10.1158/1535-7163.MCT-19-0466
Published: 06 February 2020
View article titled, On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors
Open the PDF for On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Differences in Signaling Patterns on PI3K Inhibition Reveal Context Specificity in KRAS-Mutant Cancers

Adam Stewart, Elizabeth A. Coker, Sebastian Pölsterl, Alexandros Georgiou, Anna R. Minchom, Suzanne Carreira, David Cunningham, Mary ER. O'Brien, Florence I. Raynaud, Johann S. de Bono, Bissan Al-Lazikani, Udai Banerji
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2019) 18 (8): 1396–1404.
https://doi.org/10.1158/1535-7163.MCT-18-0727
Published: 01 August 2019
View article titled, Differences in Signaling Patterns on PI3K Inhibition Reveal Context Specificity in <em>KRAS</em>-Mutant Cancers
Open the PDF for Differences in Signaling Patterns on PI3K Inhibition Reveal Context Specificity in <em>KRAS</em>-Mutant Cancers in another window
Includes: Supplementary data
Journal Articles

Abstract C37: Molecular determinants of sensitivity and resistance to FGFR inhibition in FGFR2-amplified gastric cancer

Irina Babina, Alex Pearson, Ros Cutts, Elizabeth Smyth, Jian Ning, Amanda Swain, David Cunningham, Nicholas C. Turner
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): C37.
https://doi.org/10.1158/1535-7163.TARG-15-C37
Published: 01 December 2015
View article titled, Abstract C37: Molecular determinants of sensitivity and resistance to FGFR inhibition in FGFR2-amplified gastric cancer
Journal Articles

Inhibition of Kirsten-ras Expression in Human Colorectal Cancer Using Rationally Selected Kirsten-ras Antisense Oligonucleotides

Paul J. Ross, Mark George, David Cunningham, Francesca DiStefano, H. Jervoise N. Andreyev, Paul Workman, Paul A. Clarke
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2001) 1 (1): 29–41.
Published: 01 November 2001
View article titled, Inhibition of <em>Kirsten-ras</em> Expression in Human Colorectal Cancer Using Rationally Selected <em>Kirsten-ras</em> Antisense Oligonucleotides
Open the PDF for Inhibition of <em>Kirsten-ras</em> Expression in Human Colorectal Cancer Using Rationally Selected <em>Kirsten-ras</em> Antisense Oligonucleotides in another window